Panjon share price
NSE: PANJONPharma & HealthcarePackaged Foods
Panjon at a glance
With a market capitalisation of ₹30 Cr, it ranks 3373rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Packaged Foods.
Its return on equity was 2.2% in FY16. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹12 Cr (−12.4% year on year) and net profit ₹0 Cr (−17.4%), on a standalone basis. Promoters held 56.69% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹30 CrRank 3373 on NSE
- Price to book
- 0×FY16
- EPS (TTM)
- ₹0.21to Q4 FY26
- ROE
- 2.2%FY16
- ROCE
- 0.1%FY16
- Debt to equity
- 0.08FY16
- Net profit margin
- 3.0%FY16
- Book value / share
- ₹10.57FY16
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Panjon quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2 Cr | ₹3 Cr | ₹11 Cr | ₹14 Cr | ₹6 Cr | ₹15 Cr | ₹14 Cr | ₹12 Cr |
| Revenue YoY | +68.5% | +160.0% | +132.0% | +166.0% | +207.2% | +342.3% | +26.7% | −12.4% |
| Net profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit YoY | +50.0% | +75.0% | +400.0% | +360.0% | +200.0% | +214.3% | +10.0% | −17.4% |
| Net margin | 1.4% | 2.1% | 1.8% | 1.7% | 1.4% | 1.5% | 1.6% | 1.6% |
| EPS | ₹0.02 | ₹0.04 | ₹0.12 | ₹0.01 | ₹0.06 | ₹0.13 | ₹0.01 | ₹0.01 |
Panjon financials
| Item | FY15 | FY16 |
|---|---|---|
| Revenue | ₹19 Cr | ₹12 Cr |
| Operating profit | −₹3 Cr | ₹0 Cr |
| Net profit | −₹3 Cr | ₹0 Cr |
| EPS (₹) | −₹2.00 | ₹0.00 |
| Cash from operations | ₹1 Cr | −₹0 Cr |
| Total debt | ₹1 Cr | ₹1 Cr |
| Shareholders' equity | ₹16 Cr | ₹16 Cr |
Panjon shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 56.69% | 56.69% | 56.69% | 56.69% | 56.69% | 56.69% |
| Non-institutions | 43.31% | 43.31% | 43.31% | 43.31% | 43.31% | 43.31% |
Panjon vs peers
The listed Pharma & Healthcare companies nearest to Panjon by market capitalisation.
Ask anything about Panjon
Pivot answers on the live chart with evidence you can check, and tests strategies against PANJON's own history. Try: “Why has PANJON moved over the last three months?” · “Backtest a 50-day moving-average crossover on PANJON over five years” · “Compare PANJON with DECCAN on margins and valuation”
Frequently asked questions about Panjon
What is the market cap of Panjon?
Panjon's market capitalisation is ₹30 Cr (₹30 Cr) at the 22 Oct 2026 close, ranking 3373rd among the NSE companies Pivot tracks.
What is the ROE and ROCE of Panjon?
Return on equity was 2.2% in FY16 and return on capital employed was 0.1% in FY16 (consolidated figures).
Is Panjon a debt-free company?
No. Panjon's debt-to-equity ratio was 0.08 in FY16, with total debt of ₹1 Cr.
What were Panjon's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Panjon reported revenue of ₹12 Cr, −12.4% year on year, and net profit of ₹0 Cr, −17.4% year on year.
What is the shareholding pattern of Panjon?
As of 30 Jun 2026: promoters 56.69%, non-institutions 43.31%.
Who are Panjon's competitors?
The listed Pharma & Healthcare companies closest to Panjon by market cap are Deccan Health C, Medi-Caps, KK Shah Hospita, Soni Medicare, Chennai Meenaks and Tejnaksh.
Is Panjon a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Panjon's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on PANJON against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with P · all NSE stocks · this page as text